Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b, Open-label, Multicenter, Continued Access Study for Participants Transitioning From ViiV Healthcare Sponsored or ViiV Healthcare Collaborative Parent Studies for HIV Treatment

NCT07393659 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT07393659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07393659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b, Open-label, Multicenter, Continued Access Study for Participants Transitioning From ViiV Healthcare Sponsored or ViiV Healthcare Collaborative Parent Studies for HIV Treatment
Lead sponsor
ViiV Healthcare
Phase
Phase 3
Overall status
Recruiting
Start date
July 21, 2026
Completion date
September 14, 2032
Enrollment
181 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections